Orion Misses Q4 Earnings Estimates by $0.26 EPS

Specialty chemicals company Orion reports lower-than-expected quarterly results, cuts 2026 guidance.

Published on Feb. 18, 2026

Got story updates? Submit your updates here. ›

Orion (NYSE:OEC), a global producer of carbon black, reported Q4 earnings that missed analyst estimates by $0.26 per share. The company reported a loss of $0.34 per share, compared to the consensus estimate of a loss of $0.08 per share. Orion's revenue for the quarter was $411.70 million, exceeding the $365.79 million expected by analysts.

Why it matters

Orion's disappointing earnings results and reduced 2026 guidance reflect ongoing challenges in the specialty chemicals industry, including lower demand, pricing pressures, and rising costs. The company's performance is seen as a bellwether for the broader sector, and its struggles highlight the need for chemical producers to adapt to changing market conditions.

The details

Orion cited several factors contributing to its weaker-than-expected Q4 results, including meaningful price concessions in its Rubber segment contracts for 2026 and lower industry volumes. The company also said it is cutting costs and rationalizing its manufacturing footprint, targeting $20 million in additional productivity and headcount savings. Despite the challenges, Orion expects to remain free cash flow positive in 2026 by reducing capital expenditures and benefiting from working capital improvements.

  • Orion released its Q4 2025 earnings results on Tuesday, February 17, 2026.

The players

Orion

A global producer of carbon black, a critical performance additive used in the tire, rubber, plastics, coatings, inks, and battery components industries.

Got photos? Submit your photos here. ›

What’s next

The company's La Porte conductive-carbon project has been pushed to a 2027 start, reducing 2026 capital expenditures, and management expects roughly $10 million of incremental annual depreciation once the project is online.

The takeaway

Orion's struggles reflect broader challenges facing the specialty chemicals industry, including pricing pressures, lower demand, and rising costs. The company's efforts to cut costs, improve working capital, and reduce capital expenditures aim to help it weather the current downturn, but the path to recovery remains uncertain.